D. E. Shaw & Co., Inc. Summit Therapeutics Inc. Transaction History

D. E. Shaw & Co., Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$2.0 - $3.45 $30,292 - $52,253	-15,146 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$2.45 - $5.64 $19,609 - $45,142	-8,004 Reduced 34.57%	15,146 $41,000
Q3 2021 Nov 15, 2021	BUY	$4.83 - $8.27 $62,732 - $107,410	12,988 Added 127.81%	23,150 $116,000
Q2 2021 Aug 16, 2021	BUY	$5.15 - $8.46 $52,334 - $85,970	10,162 New	10,162 $76,000

107

41.3M

103K

29.9K

Ticker SMMT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 201,215,008
Market Cap $1.46B
Description
Summit Therapeutics Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat infectious diseases in the United States and Latin America. It conducts clinical programs focusing on Clostridioides difficile infection (CDI). The company's lead product candidate is ridinilazole, an orally administered small molecu...

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.